Sanofi Consumer Healthcare India First Quarter 2025 Earnings: EPS: ₹21.69 (vs ₹65.27 in 1Q 2024)

Simply Wall St · 05/09 00:13

Sanofi Consumer Healthcare India (NSE:SANOFICONR) First Quarter 2025 Results

Key Financial Results

  • Revenue: ₹1.73b (down 67% from 1Q 2024).
  • Net income: ₹500.0m (down 67% from 1Q 2024).
  • Profit margin: 29% (in line with 1Q 2024).
  • EPS: ₹21.69 (down from ₹65.27 in 1Q 2024).
We've discovered 1 warning sign about Sanofi Consumer Healthcare India. View them for free.
earnings-and-revenue-growth
NSEI:SANOFICONR Earnings and Revenue Growth May 9th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Sanofi Consumer Healthcare India Earnings Insights

Looking ahead, revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Pharmaceuticals industry in India.

Performance of the Indian Pharmaceuticals industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 1 warning sign for Sanofi Consumer Healthcare India you should be aware of.